Compound preparation for neuranagenesis, and preparation method therefor and use thereof

US12115204B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12115204-B2
Application numberUS-202117790646-A
CountryUS
Kind codeB2
Filing dateJan 5, 2021
Priority dateJul 20, 2020
Publication dateOct 15, 2024
Grant dateOct 15, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are a compound preparation for neuranagenesis, and a preparation method therefor and the use thereof. The compound preparation for neuranagenesis comprises the raw medicinal materials in parts by weight: 10-20 parts of raw Astragali radix , 10-20 parts of Rehmaimiae Radix praeparata , 10-20 parts of Actyranthes bidentata , 6-15 parts of Jujubae fructus , 6-15 parts of Lycii fructus , 6-15 parts of parched Ziziphi spinosae semen, 6-12 parts of Angelicae smensis radix , 3-9 parts of Carthami flos , 6-15 parts of Poria , 6-15 parts of parched Atractylodis macrocephalae rhizoma and 10-20 parts of Zaocys . The compound preparation can be used for preparing drugs to treat nerve damage diseases, and can be prepared into oral liquids, granules, dissolved granules and tablets.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound preparation for neuranagenesis, wherein the compound preparation comprises the raw medicinal materials in parts by weight: 10-20 parts of raw Astragali radix, 10-20 parts of Rehmanniae Radix praeparata, 10-20 parts of Achyranthes bidentata, 6-15 parts of Jujubae fructus, 6-15 parts of Lycii fructus, 6-15 parts of parched Ziziphi spinosae semen, 6-12 parts of Angelicae sinensis radix, 3-9 parts of Carthami flos, 6-15 parts of Poria, 6-15 parts of parched Atractylodis macrocephalae rhizoma and 10-20 parts of Zaocys , and the dosage form of the compound preparation for neuranagenesis comprises oral liquid prepared by: soaking the raw materials in deionized water at 25° C. for 120 min; performing water extraction, and decocting at 100° C. for 20 min; taking the decoction and allowing same to stand at 4° C. for 12 h under sterile conditions, performing filtration and concentration, and adding benzoic acid or sodium benzoate; and performing filling and sterilization to obtain the oral liquid. 2. The compound preparation for neuranagenesis according to claim 1 , wherein the compound preparation comprises the raw medicinal materials in parts by weight: 15 parts of raw Astragali radix, 15 parts of Rehmanniae Radix praeparata, 15 parts of Achyranthes bidentata, 10 parts of Jujubae fructus, 10 parts of Lycii fructus, 10 parts of parched Ziziphi spinosae semen, 6 parts of Angelicae sinensis radix, 3 parts of Carthami flos, 10 parts of Poria, 10 parts of parched Atractylodis macrocephalae rhizoma and 15 parts of Zaocys. 3. The compound preparation for neuranagenesis according to claim 2 , wherein the compound preparation also comprises an effective dose of the formulation components of the compound preparation and pharmaceutically acceptable excipients. 4. A method for preparing the compound preparation for neuranagenesis according to claim 3 , wherein when the dosage form of the compound preparation is oral liquid, the preparation method further comprises the following step: preparing raw materials in parts by weight: 15 parts of raw Astragali radix, 10 parts of Jujubae fructus, 15 parts of Rehmanniae Radix praeparata, 10 parts of Lycii fructus, 15 parts of Achyranthes bidentata, 10 parts of parched Ziziphi spinosae semen, 6 parts of Angelicae sinensis radix, 3 parts of Carthami flos, 10 parts of Poria, 10 parts of parched Atractylodis macrocephalae rhizoma and 15 parts of Zaocys , and rinsing the medicinal materials with water to remove impurities. 5. A method for preparing the compound preparation for neuranagenesis according to claim 3 , wherein when the dosage form of the compound preparation is granules, the preparation method further comprises the following step: preparing raw materials in parts by weight: 15 parts of raw Astragali radix, 10 parts of Jujubae fructus, 15 parts of Rehmanniae Radix praeparata, 10 parts of Lycii fructus, 15 parts of Achyranthes bidentata, 10 parts of parched Ziziphi spinosae semen, 6 parts of Angelicae sinensis radix, 3 parts of Carthami flos, 10 parts of Poria, 10 parts of parched Atractylodis macrocephalae rhizoma and 15 parts of Zaocys , and rinsing the medicinal materials with water to remove impurities. 6. A method of treating nerve damage diseases comprising administering a therapeutically effective amount of the compound preparation for neuranagenesis according to claim 1 . 7. A compound preparation for neuranagenesis, wherein the compound preparation comprises the raw medicinal materials in granules: 15 parts of raw Astragali radix, 10 parts of Jujubae fructus, 15 parts of Rehmanniae Radix praeparata, 10 parts of Lycii fructus, 15 parts of Achyranthes bidentata, 10 parts of parched Ziziphi spinosae semen, 6 parts of Angelicae sinensis radix, 3 parts of Carthami flos, 10 parts of Poria, 10 parts of parched Atractylodis macrocephalae rhizoma and 15 parts of Zaocys , and rinsing the medicinal materials with water to remove impurities, and the dosage form of the compound preparation for neuranagenesis comprises granules prepared by: soaking the raw materials in deionized water at 25° C. for 120 min; performing water extraction, and decocting at 100° ° C. for 20 min; taking the decoction and allowing same to stand at 4° C. for 12 h under sterile conditions, performing filtration and concentration, and adding benzoic acid or sodium benzoate; and performing drying, granulation, filling and sterilization to obtain the granules.

Assignees

Inventors

Classifications

  • Snakes; Lizards, e.g. chameleons (therapeutic use of a snake venom protein A61K38/00) · CPC title

  • Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying · CPC title

  • using water, e.g. cold water, infusion, tea, steam distillation or decoction · CPC title

  • involving cleaning, e.g. washing or peeling · CPC title

  • Lycium (desert-thorn) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12115204B2 cover?
Disclosed are a compound preparation for neuranagenesis, and a preparation method therefor and the use thereof. The compound preparation for neuranagenesis comprises the raw medicinal materials in parts by weight: 10-20 parts of raw Astragali radix , 10-20 parts of Rehmaimiae Radix praeparata , 10-20 parts of Actyranthes bidentata , 6-15 parts of Jujubae fructus , 6-15 parts of Lycii fruct…
Who is the assignee on this patent?
Univ Nantong
What technology area does this patent fall under?
Primary CPC classification A61K36/481. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).